NCT01880619View on ClinicalTrials.gov

Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions
Relieve of Ureteral Stent Symptoms
Interventions
DRUG

Tamsulosin

Patients in this arm will receive Tamsulosin 0.4 mg daily

DRUG

Solifenacin

Patients in the arm will receive Solifenacin

DRUG

Control

Patients in this are will receive placebo

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT01880619 - Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms | Biotech Hunter | Biotech Hunter